Discovery

Stallion Uranium Announces Successful Completion of Ground EM Survey on the Coffer Uranium Project

Retrieved on: 
Wednesday, January 24, 2024
TDEM, Probability, STUD, Uranium, Appaloosa, Discovery, Data, Ground, EM, Anomaly, Stallion

VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: HM40) is pleased to announce the completion of ground-based time-domain electromagnetic (EM) geophysical survey over the high priority Appaloosa Target on its 100% owned Coffer Uranium Project (“Coffer” or the “Project”) in the prolific Athabasca Basin, Saskatchewan.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: HM40) is pleased to announce the completion of ground-based time-domain electromagnetic (EM) geophysical survey over the high priority Appaloosa Target on its 100% owned Coffer Uranium Project (“Coffer” or the “Project”) in the prolific Athabasca Basin, Saskatchewan.
  • The data has now moved into final processing and modeling to be available as Stallion prepares for their maiden drill program.
  • Stallion Uranium engaged Discovery International Geophysics Inc (“Discovery”) for the ground TDEM survey over the Appaloosa Target on the Coffer Project as outlined in Figure 1.
  • The EM survey is capable of penetrating far beyond the estimated unconformity depth and will provide the best targets for drilling testing.

Why Industry Experts Are Expecting a Bull Market For Uranium Stocks In 2024

Retrieved on: 
Wednesday, January 24, 2024
TDEM, STUD, Uranium, Appaloosa, Discovery, UEC, Mining, Government, Data, Sale, Ground, TSX, EM, OTCQX, Stallion, Projection, Anomaly, FCU, News, Glacier Media, PALM, Uranium mining

Stockhead recently trumpeted, “Uranium has started 2024 the same way it ended 2023—like a bull in a china shop.

Key Points: 
  • Stockhead recently trumpeted, “Uranium has started 2024 the same way it ended 2023—like a bull in a china shop.
  • Furthermore, market analysts project an average supply deficit of 35 million pounds per year over the next decade.
  • The latter company plans to increase its uranium production to 22 million pounds this year.
  • As of early 2024, SPUT had impounded more than 63 million pounds of uranium.

CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics

Retrieved on: 
Tuesday, January 23, 2024
Translation, MJFF, Patient, Risk, Research, Discovery, Genetics, PD, Neurodegenerative disease, Disease, Observational study, Therapy, GBA, Genomics, Parkinson's disease, Pharmaceutical industry

Fox Foundation for Parkinson’s Research (MJFF), a non-profit organization dedicated to finding a cure for Parkinson’s disease (PD), today announced a research project to accelerate research on genetic risk factors associated with PD, specifically targeting the role of variants in the GBA (glucosylceramidase beta) gene.

Key Points: 
  • Fox Foundation for Parkinson’s Research (MJFF), a non-profit organization dedicated to finding a cure for Parkinson’s disease (PD), today announced a research project to accelerate research on genetic risk factors associated with PD, specifically targeting the role of variants in the GBA (glucosylceramidase beta) gene.
  • PD is a devastating neurodegenerative disease affecting over 10 million people worldwide, with many cases being linked to genetic factors.
  • The research project will leverage CENTOGENE’s expertise in rare genetic and neurodegenerative diseases, drawing on diverse multiomic data in the CENTOGENE Biodatabank.
  • Fox Foundation is an inspirational leader in Parkinson’s disease research.

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy

Retrieved on: 
Tuesday, January 23, 2024
Senior, Patient, Diabetic neuropathy, Oxaliplatin, Research, CIPN, Peripheral neuropathy, Chemotherapy-induced peripheral neuropathy, Discovery, Cancer, The Journal of Pain, IND, Food, Neuropathic pain, FDA, Pain, Doctor of Philosophy, FABP5, Fatty acid, Pharmaceutical industry

The research article, titled “ Discovery and preclinical evaluation of a novel inhibitor of FABP5, ART26.12, effective in Oxaliplatin-induced Peripheral Neuropathy ,” highlights Artelo’s pre-clinical asset, ART26.12, and its potential ability to treat and prevent Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in a series of separate studies.

Key Points: 
  • The research article, titled “ Discovery and preclinical evaluation of a novel inhibitor of FABP5, ART26.12, effective in Oxaliplatin-induced Peripheral Neuropathy ,” highlights Artelo’s pre-clinical asset, ART26.12, and its potential ability to treat and prevent Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in a series of separate studies.
  • ART26.12 is a Fatty Acid Binding Protein 5 (FABP5) inhibitor in development for the treatment of chemotherapy-induced peripheral neuropathy (CIPN), a type of neuropathic pain caused by chemotherapy as well as non-chemotherapy cancer treatments such as immunomodulating drugs.
  • Artelo has conducted multiple pre-clinical studies in painful neuropathies, including diabetic neuropathy, paclitaxel-induced peripheral neuropathy, and OIPN, the latter two of which has no FDA-approved treatment.
  • The Company previously reported a positive pre-IND (investigational new drug) meeting with the Food and Drug Administration (FDA) and anticipates filing the IND for ART26.12 in the first half of 2024.

Alberta Cancer Foundation announces initial investment of its novel philanthropic Breakthrough Fund to support early-stage cancer research

Retrieved on: 
Tuesday, January 23, 2024
Neoplasm, Patient, Thought, Research, PLV, Health, DNA, Biotechnology, Discovery, Alberta Health Services, Breakthrough, Cancer, FAST, Fund, Risk, Quality of life, Immunotherapy, Drug discovery, Investment, Therapy, Nature, Diagnosis, Pharmaceutical industry

This Fund evolves the traditional model of philanthropy, positioning donors as investors in the health and wealth of the community.

Key Points: 
  • This Fund evolves the traditional model of philanthropy, positioning donors as investors in the health and wealth of the community.
  • “The Alberta Cancer Foundation recognized the need to actively move ideas from research through to market in order to truly transform patient outcomes, survival rates and quality of life,” said Wendy Beauchesne, CEO, Alberta Cancer Foundation.
  • Earlier this month, the Alberta Cancer Foundation was pleased to announce Entos Pharmaceuticals and 48Hour Discovery were each awarded $100,000 to advance their research in cancer treatment options.
  • Recent cancer immunotherapy treatment advancements demonstrate the effectiveness of personalized DNA vaccines and Entos plans to use Breakthrough funding to propel its research to the next stage.

2024 Japan Prize: Three Scientists from US and UK have been awarded

Retrieved on: 
Monday, January 29, 2024
Philanthropy, Health, Foundation, Research, Science, Pharmaceutical, Biotechnology, Weather, Medicine, Discovery, Pharmacy, Drug development, Pharmaceutical industry

The Japan Prize Foundation announced the winners of the 2024 Japan prize at 1PM, 23 January, 2024.

Key Points: 
  • The Japan Prize Foundation announced the winners of the 2024 Japan prize at 1PM, 23 January, 2024.
  • Prof. Sir Brian J. Hoskins (UK) and Prof. John Michael Wallace (USA) are co-winners of the Japan Prize in the fields of Resources, Energy, the Environment, and Social Infrastructure, and Prof. Ronald M. Evans (USA) has been awarded the Japan Prize in the fields of Medical Science and Pharmaceutical Science.
  • For the 2024 Japan Prize, the Foundation asked approximately 15,500 prominent scientists and engineers from around the world to nominate researchers working in this year’s fields.
  • We received 130 nominations for the fields of Resources, Energy, Environment, and Social Infrastructure, and 198 nominations for the fields of Medical Science and Pharmaceutical Science.

Santa Clara University Celebrates History-Making $1 Billion Fundraising Milestone

Retrieved on: 
Sunday, January 28, 2024
Fund Raising, Foundation, Philanthropy, University, Education, Silicon, Student, Light, Learning, Music, Campaign, NBA, Diversity, Person, STEM, SCU, Knowledge, Friends, Faculty, Discovery, Innovation, Mental health, Trustee, Santa Clara University, Performing arts, MBA, News, Catholic higher education, Golden Circle, Parent, Catholic Church, Football, Nursing

Santa Clara University today celebrated a rare and prestigious milestone: the completion of its $1 billion Innovating with a Mission campaign, the largest comprehensive fundraising campaign in the University’s 173-year history.

Key Points: 
  • Santa Clara University today celebrated a rare and prestigious milestone: the completion of its $1 billion Innovating with a Mission campaign, the largest comprehensive fundraising campaign in the University’s 173-year history.
  • The record total of $1.017 billion reflects contributions from more than 46,000 alumni, corporations, foundations, parents and other friends of Santa Clara.
  • Santa Clara now becomes the fourth Catholic university in the United States to reach that $1 billion goal.
  • “This Campaign marks a key moment in Santa Clara University’s ascent as one of the nation’s leading institutions of higher learning,” said Larry Sonsini, chair of Santa Clara University’s Board of Trustees.

EDO Announces Most Effective Programs for Advertisers That Drove TV Outcomes in 2023

Retrieved on: 
Thursday, January 25, 2024
Digital Marketing, Data Analytics, TV and Radio, Content Marketing, Advertising, Communications, Professional Services, Entertainment, Baking It, NBC, Univision, CBS, Discovery, ABC, HGTV, FOX, English, Gold, Paramount Network, Television

EDO , the TV outcomes company, released today a ranking of the most effective primetime programs of 2023 across English- and Spanish-language media.

Key Points: 
  • EDO , the TV outcomes company, released today a ranking of the most effective primetime programs of 2023 across English- and Spanish-language media.
  • The top 10 primetime broadcast programs accounted for six different genres, including comedy & variety, drama, documentary, and game shows.
  • Yellowstone (CBS) and 1883: A Yellowstone Origin Story (Paramount Network) emerged as two of the most effective programs for advertisers.
  • At EDO, we validate savvy media buying and effective messaging with the market’s most trustworthy predictive outcomes data.

PlayOn! Sports Announces James Rosenstock as Chief Financial Officer

Retrieved on: 
Monday, January 29, 2024
Special, Rosenstock, CFO, School, Discovery, Information technology, TMT, Security, Accounting, Sport, EzCater, DTC, B2B, PMO, K-12, SONY, Child, VICE, WWE, Skillshare, PlayOn, Growth, Management

ATLANTA, Jan. 29, 2024 /PRNewswire/ -- PlayOn! Sports, a leading high school media and technology company, today announced the appointment of James "Jay" Rosenstock as Chief Financial Officer (CFO).

Key Points: 
  • Seasoned financial, operational and strategic leader brings deep media and technology expertise to drive future growth and innovation in K-12 space.
  • Sports, a leading high school media and technology company, today announced the appointment of James "Jay" Rosenstock as Chief Financial Officer (CFO).
  • At PlayOn!, Rosenstock will oversee the Accounting, Finance, Tax, M&A, Information Technology and Security and Project Management Office (PMO) departments.
  • Earlier, Rosenstock was instrumental in architecting and operating Discovery's international businesses, where he oversaw Discovery Education International.

Over 6,200 Delegates Attend Annual AME Roundup Conference in Vancouver

Retrieved on: 
Monday, January 29, 2024
Carbon, Canada Research Chair, Senior, Assistant, Learning, Associate, Executive Committee, Metal, Faculty, Foreign policy, Ministry of Energy, Knowledge, Skeena, Discovery, Mining, Government, Discovery Day, First Nations, Faculty (division), Climate change, Fasken, Human, Mineral, Ministry, Growth

VANCOUVER, BC, Jan. 29, 2024 /CNW/ - Last week, the Association for Mineral Exploration (AME) hosted its 41st annual AME Roundup conference, the largest global gathering of the mineral exploration industry.

Key Points: 
  • VANCOUVER, BC, Jan. 29, 2024 /CNW/ - Last week, the Association for Mineral Exploration (AME) hosted its 41st annual AME Roundup conference, the largest global gathering of the mineral exploration industry.
  • AME appreciated the government's acknowledgement at AME Roundup that more action is required to facilitate the development of new critical mineral projects.
  • AME congratulates Justin Himmelright, Senior Vice President, External Affairs at Skeena Resources as the newly appointed Chair of the AME Board.
  • Mark your calendars for AME Roundup 2025, Monday, January 20 to Thursday, January 23, 2025, at the Vancouver Convention Centre East.